FDA Biologics (BLA & Biosimilars)Original article
Biotestcell and Erytypecell
RegulatoryapprovedBiotestcellReagent Red Blood CellsPositive
AI Analysis
Summary
Biotestcell and Erytypecell products received approval for use in manual tube testing and automated blood grouping and antibody testing on the TANGO optimo system. These are routine diagnostic product approvals with limited market impact.
Outcome Details
Product approval for use in manual tube testing and automated blood grouping systems
Importance:4/10
Sentiment:
0.60
regulatory approvalblood groupingdiagnosticsautomated systems
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on July 6, 2026 9:30 PM